Vanguard Capital Wealth Advisors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1730578
DENVER, CO
Position in VRTX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$263,266
+$26,600 QoQ
Shares Held
530
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,288
of 1,735 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard Capital Wealth Advisors holds $1,003,641 across 3 Biotechnology names. VRTX ranks #2 (26.2% of the industry book) .
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,266 | 530 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $236,666 | 530 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $240,280 | 530 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $207,569 | 530 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $249,312 | 560 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $271,499 | 560 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $227,525 | 565 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $304,627 | 655 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $393,724 | 840 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $351,128 | 840 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $337,718 | 830 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $372,081 | 1,070 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $309,680 | 880 | Shares | Sole | 2023-11-01 | |
| 2023-03-31 | $277,261 | 880 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $254,126 | 880 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $231,632 | 800 | Shares | Sole | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||